EMAIL THIS PAGE TO A FRIEND

Nanoscale

Magnetic bead-quantum dot assay for detection of a biomarker for traumatic brain injury.


PMID 26457768

Abstract

Current diagnostic methods for traumatic brain injury (TBI), which accounts for 15% of all emergency room visits, are limited to neuroimaging modalities. The challenges of accurate diagnosis and monitoring of TBI have created the need for a simple and sensitive blood test to detect brain-specific biomarkers. Here we report on an assay for detection of S100B, a putative biomarker for TBI, using antibody-conjugated magnetic beads for capture of the protein, and antibody-conjugated quantum dots for optical detection. From Western Blot, we show efficient antigen capture and concentration by the magnetic beads. Using magnetic bead capture and quantum dot detection in serum samples, we show a wide detection range and detection limit below the clinical cut-off level.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

P3531
1,2-Distearoyl-sn-glycero-3-phosphoethanolamine, ≥99%
C41H82NO8P